ENTITY

REGENXBIO Inc (RGNX US)

15
Analysis
Health CareUnited States
REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant, and adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.
more
Company Event25 Feb 2026 01:30 • Upcoming
Add To Calendar
Company Event02 Dec 2025 21:30 • Latest
Company Event12 Nov 2025 02:20
Company Event06 Nov 2025 21:00
x